Facility Inspections Factor in Slow Generics Reviews, says GAO
The FDA is improving its response times for generic drug applications, but facility inspections remain a major hang-up in the process, according to a GAO report. Source: Drug GMP Report
The FDA is improving its response times for generic drug applications, but facility inspections remain a major hang-up in the process, according to a GAO report. Source: Drug GMP Report
Persistent problems with quality will draw continued scrutiny and citations from the FDA, regardless of company size. Source: Drug GMP Report
The FDA broadened its import ban against Indian manufacturer Ipca Laboratories to include four drugs previously exempted due to shortage. The drugmaker’s continued GMP violations already kept most of the…
Companies that are not keeping up with GMP cleanliness and sterility requirements are likely to get more than just a Form 483 from the FDA—they may get multiple visits from…
A federal district judge shut down drugmaker Stratus Pharmaceuticals in Florida and distributor Sonar Products of New Jersey with a permanent injunction Thursday. Source: Drug GMP Report
Phillips Co. is voluntarily recalling all lots of Tetrastem, Diabecline, Tetracycline-ABC, VenomX, Acneen, StaphWash, StringMed, NoPain and LidoMed after an FDA inspection found significant manufacturing practices that call into question…
Phillips Co. is voluntarily recalling all lots of Tetrastem, Diabecline, Tetracycline-ABC, VenomX, Acneen, StaphWash, StringMed, NoPain and LidoMed after an FDA inspection found significant manufacturing practices that call into question…
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-mannkind.jpg" NAME"Struggling MannKind Hires Financial Advisor After Maxing Out Its Last Credit Line" ALT"Struggling MannKind Hires Financial Advisor After Maxing Out Its Last Credit Line"June 30, 2017By Alex Keown,…
Life Sciences Jobs ... Source: BioSpace